INSILICO TAIWAN LTD.
Booth No: M906
Insilico Medicine, an artificial intelligence company pioneered the applications of the generative adversarial networks (GANs), reinforcement learning, transfer learning and meta-learning for generation of novel molecular structures for the diseases with known and unknown targets. Insilico Medicine is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging. (More Info: www.insilico.com)
Exhibitor Press Release
Exhibitors you may be interested in